IGF-1 DES Peptide

IGF-1 DES (1-3) is a synthetic truncated analogue of insulin-like growth factor 1 (IGF-1). It has attracted significant scientific interest due to its association with cellular signalling pathways, growth factor research, and biological regulatory mechanisms. Its modified structure distinguishes it from native IGF-1 and has led to its inclusion in a variety of experimental research models.

Researchers have investigated IGF-1 DES (1-3) across studies examining cell signalling processes, growth factor interactions, and broader biological communication systems. Its well-characterised structure has made it a frequently referenced compound within peptide and cellular biology research.

Research Overview

IGF-1 DES (1-3) is commonly studied in relation to:

• Growth factor signalling pathway investigations
• Cellular communication and regulatory mechanism research
• Cell proliferation and differentiation studies
• Peptide-receptor interaction research
• Muscle tissue and structural biology research models
• Cellular signalling and biological regulation investigations

As a modified analogue of IGF-1, IGF-1 DES (1-3) continues to be examined in research exploring complex signalling networks and growth factor-mediated biological processes.

Key Characteristics

• Synthetic truncated analogue of IGF-1
• Purity ≥98% (HPLC verified)
• Supplied as lyophilised powder
• Frequently studied in growth factor and cellular signalling research
• Suitable for laboratory and scientific research applications

Product Specifications

• Available quantities: 1mg, 5mg, and 10mg
• Lyophilised powder format
• Purity ≥98% (HPLC verified)
• Store in a cool, dry place
• Reconstituted solutions should be refrigerated

Important Information

• Supplied for research purposes only
• Not for human or veterinary use
• Not intended for consumption
• This product is not intended to diagnose, treat, cure, or prevent any disease
• Purchasers are responsible for ensuring compliance with local laws and regulations